A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2.
A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2.
复制标题
小分子化合物 IMB-LA 通过阻止病毒 Vpu 拮抗宿主限制因子 BST-2 来抑制 HIV-1 感染。
DOI:
10.1038/srep18499
复制
发表时间:
2015-12-16
影响因子:
4.6
通讯作者:
Cen S
中科院分区:
文献类型:
--
作者:
Mi Z;Ding J;Zhang Q;Zhao J;Ma L;Yu H;Liu Z;Shan G;Li X;Zhou J;Wei T;Zhang L;Guo F;Liang C;Cen S
Human BST-2 inhibits HIV-1 replication by tethering nascent virions to the cell surface. HIV-1 codes Vpu that counteracts BST-2 by down-regulating this restriction factor from the cell surface. This important function makes Vpu a potential therapeutic target. Yet, no agents have been reported to block Vpu from antagonizing BST-2. In this study, we report a small molecule compound IMB-LA that abrogates the function of Vpu and thereby strongly suppresses HIV-1 replication by sensitizing the virus to BST-2 restriction. Further studies revealed that IMB-LA specifically inhibits Vpu-mediated degradation of BST-2 and restores the expression of BST-2 at the cell surface. Although IMB-LA does not prevent Vpu from interacting with BST-2 or β-TrCP2-containing ubiquitin E3 ligase, sorting of BST-2 into lysosomes in Vpu-expressing cells is blocked by IMB-LA. Most importantly, HIV-1 release and infection is inhibited by IMB-LA only in BST-2-expressing cells. In summary, results herein demonstrated that IMB-LA could specifically inhibit the degradation of BST-2 induced by Vpu and impair HIV-1 replication in a BST-2 dependent manner, suggesting the feasibility of utilizing small molecule compounds to disable the antagonist function of Vpu and thereby expose HIV-1 to the restriction by BST-2.
影响因子:
3.7
作者:
Ruiz A;Lau D;Mitchell RS;Hill MS;Schmitt K;Guatelli JC;Stephens EB
通讯作者:
Stephens EB